{
    "clinical_study": {
        "@rank": "27010", 
        "brief_summary": {
            "textblock": "The purpose of this research study is to evaluate the safety and effectiveness of Interferon\n      gamma-1b (IFN-g 1b) on lung function when given to patients with cystic fibrosis by\n      inhalation (breathed into the lungs) three times a week for 12 weeks.\n\n      The FDA has not approved Interferon gamma-1b for use with cystic fibrosis patients, which is\n      the condition being examined in this study."
        }, 
        "brief_title": "Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis", 
        "completion_date": {
            "#text": "October 2002", 
            "@type": "Actual"
        }, 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key inclusion criteria:\n\n          -  At least 12 years of age\n\n          -  Diagnosis of cystic fibrosis with mild to moderate pulmonary impairment\n\n          -  Must be receiving ongoing chronic treatment with TOBI (inhaled tobramycin) OR not\n             receiving ongoing chronic treatment with TOBI and no use of TOBI or other inhaled\n             antibiotic within 4 weeks prior to study drug administration\u00b7\n\n          -  Other specific diagnostic indicators of CF and other factors must meet minimum\n             requirements."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 7, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00043316", 
            "org_study_id": "GICF-001"
        }, 
        "intervention": {
            "description": "500 or 1000 mcg, inhalation, 3x per week", 
            "intervention_name": "interferon gamma-1b", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Interferon-gamma", 
                "Interferons"
            ]
        }, 
        "keyword": [
            "cystic fibrosis", 
            "pulmonary impairment"
        ], 
        "lastchanged_date": "October 29, 2007", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palo Alto", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sacramento", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daytona Beach", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York City", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lackland AFB", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tyler", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase I/II Study of Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis", 
        "overall_official": {
            "affiliation": "InterMune", 
            "last_name": "Steve Porter, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_outcome": {
            "measure": "change in FEV1, sputum bacterial density", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00043316"
        }, 
        "source": "InterMune", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "InterMune", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2007"
    }, 
    "geocoordinates": {
        "null": "32.351 -95.301"
    }
}